+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neoantigen"

T-Cell Immunotherapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

T-Cell Immunotherapy Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 187 Pages
  • Global
From
Cancer Immunotherapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer Immunotherapy Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 183 Pages
  • Global
From
From
Immuno-Oncology Service Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immuno-Oncology Service Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 190 Pages
  • Global
From
Immuno-Oncology Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immuno-Oncology Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 197 Pages
  • Global
From
From
From
From
Cancer Biological Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Biological Therapy - Global Strategic Business Report

  • Report
  • August 2026
  • 211 Pages
  • Global
From
Precision Oncology Market - Global Strategic Business Report - Product Thumbnail Image

Precision Oncology Market - Global Strategic Business Report

  • Report
  • August 2026
  • 382 Pages
  • Global
From
From
Cancer Gene Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer Gene Therapy Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 182 Pages
  • Global
From
Allogeneic T Cell Therapies Market Report 2026 - Product Thumbnail Image

Allogeneic T Cell Therapies Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Intratumoral Cancer Therapies Market Report 2026 - Product Thumbnail Image

Intratumoral Cancer Therapies Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Loading Indicator

The Neoantigen market is a subset of the Genomics market that focuses on the identification and development of neoantigens for use in cancer immunotherapy. Neoantigens are proteins that are produced by tumor cells and are recognized by the immune system as foreign, triggering an immune response. By targeting these neoantigens, cancer immunotherapy can be used to treat cancer. Companies in the Neoantigen market are focused on developing technologies to identify and develop neoantigens for use in cancer immunotherapy. Companies in the Neoantigen market include Adaptive Biotechnologies, I-Mab, Neoantigen Therapeutics, NeoVax, and OncoImmune. Show Less Read more